TransMedics logo

TransMedics

TMDX | NASDAQ
Chart Builder DCF Calculator
$92.21
+$0.83 (+0.91%)
At close: Nov 16, 2026, 4:00 PM ET
$91.55
-$0.66 (-0.72%)
After-hours: Nov 16, 2026, 7:41 PM ET
+0.91%

Rating

Updated: Nov 16, 2026
61.3
Fundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #122/1021 (Top 12%)

Key Statistics

Market Data

Market Cap $3.2B
1D Range
89.50 92.99
52W Range
62.04 150.42

Valuation (TTM)

PE 25.19
PB 5.82
EV/EBITDA 25.72

Valuation (NTM)

Forward PE 56.06
Forward PEG -0.58
Price Target $106.00
Loading financial charts...

Profile

TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stag...

Sector Healthcare
Employees 898
IPO Date May 2, 2019
Fiscal Year January - December

Latest News

Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

4 days ago · prnewswire.com

Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
TransMedics: 2027 Setting Up To Be A Pivotal Year

5 days ago · seekingalpha.com

TransMedics: 2027 Setting Up To Be A Pivotal Year
TransMedics (TMDX) Just Reclaimed the 200-Day Moving Average

6 days ago · zacks.com

TransMedics (TMDX) Just Reclaimed the 200-Day Moving Average
TransMedics: Growth Is Accelerating Again And 2027 Looks Promising

6 days ago · seekingalpha.com

TransMedics: Growth Is Accelerating Again And 2027 Looks Promising
TransMedics: 3 Key Takeaways for Long-Term Investors

7 days ago · fool.com

TransMedics: 3 Key Takeaways for Long-Term Investors
TransMedics (TMDX) Just Flashed Golden Cross Signal: Do You Buy?

8 days ago · zacks.com

TransMedics (TMDX) Just Flashed Golden Cross Signal: Do You Buy?
TransMedics (TMDX) Recently Broke Out Above the 50-Day Moving Average

8 days ago · zacks.com

TransMedics (TMDX) Recently Broke Out Above the 50-Day Moving Average
TransMedics Group Q3 Earnings Call Highlights

10 days ago · marketbeat.com

TransMedics Group Q3 Earnings Call Highlights
Unusual Options Volume Report: 3 Stocks Moving After Earnings

11 days ago · schaeffersresearch.com

Unusual Options Volume Report: 3 Stocks Moving After Earnings
TransMedics (TMDX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

11 days ago · zacks.com

TransMedics (TMDX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Earnings

Latest Earnings
Nov 5, 2026
EPS
$0.51
Beat +71.37%
REV
$203.01M
Beat +14.01%
Next Earnings
Feb 23, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
10
Consensus
Buy
Price Target
$106.00
Upside
+14.95%
Buy (6)
Hold (4)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.